These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1923526)

  • 1. Frequent p53 mutations in chemically induced murine fibrosarcoma.
    Halevy O; Rodel J; Peled A; Oren M
    Oncogene; 1991 Sep; 6(9):1593-600. PubMed ID: 1923526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
    Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
    Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meth A fibrosarcoma cells express two transforming mutant p53 species.
    Eliyahu D; Goldfinger N; Pinhasi-Kimhi O; Shaulsky G; Skurnik Y; Arai N; Rotter V; Oren M
    Oncogene; 1988 Sep; 3(3):313-21. PubMed ID: 3060794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
    Takahashi T; D'Amico D; Chiba I; Buchhagen DL; Minna JD
    J Clin Invest; 1990 Jul; 86(1):363-9. PubMed ID: 2164047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Methylcholanthrene inactivates the p53 gene in Syrian hamster embryo fibroblasts by inducing a specific intronic point mutation.
    Albor A; Flessate DM; Soussi T; Notario V
    Cancer Res; 1994 Aug; 54(16):4502-7. PubMed ID: 8044802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of mouse p53 yeast functional assay and evaluation of its detectability of p53 gene mutation].
    Tsunematsu I
    Hokkaido Igaku Zasshi; 1999 Jul; 74(4):301-14. PubMed ID: 10480037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression.
    Steinmeyer K; Maacke H; Deppert W
    Oncogene; 1990 Nov; 5(11):1691-9. PubMed ID: 2267135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in bladder carcinoma cell lines.
    Cooper MJ; Haluschak JJ; Johnson D; Schwartz S; Morrison LJ; Lippa M; Hatzivassiliou G; Tan J
    Oncol Res; 1994; 6(12):569-79. PubMed ID: 7787250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
    Kamihira S; Terada C; Sasaki D; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y
    Eur J Haematol; 2009 Apr; 82(4):301-7. PubMed ID: 19220422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
    Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
    Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).
    Yam JW; Zheng JY; Hsiao WL
    Biochem Biophys Res Commun; 1999 Dec; 266(2):472-80. PubMed ID: 10600527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
    Liu Y; Bodmer WF
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectra of X-ray-induced and spontaneous intragenic HPRT mutations in closely related human cells differentially expressing the p53 tumor suppressor gene.
    Phillips EN; Gebow D; Liber HL
    Radiat Res; 1997 Feb; 147(2):138-47. PubMed ID: 9008205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
    Clarke AR; Cummings MC; Harrison DJ
    Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.